Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals.

Downing NS, Shah ND, Neiman JH, Aminawung JA, Krumholz HM, Ross JS.

Trials. 2016 Apr 14;17:199. doi: 10.1186/s13063-016-1322-4.

2.

Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 Years.

Kragholm K, Halim SA, Yang Q, Schulte PJ, Hochman JS, Melloni C, Mahaffey KW, Moliterno DJ, Harrington RA, White HD, Armstrong PW, Ohman EM, Van de Werf F, Tricoci P, Alexander JH, Giugliano RP, Newby LK.

Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):357-67. doi: 10.1161/CIRCOUTCOMES.114.001615. Epub 2015 Jul 7.

3.

Coronary Computed Tomography Angiography Versus Radionuclide Myocardial Perfusion Imaging in Patients With Chest Pain Admitted to Telemetry: A Randomized Trial.

Levsky JM, Spevack DM, Travin MI, Menegus MA, Huang PW, Clark ET, Kim CW, Hirschhorn E, Freeman KD, Tobin JN, Haramati LB.

Ann Intern Med. 2015 Aug 4;163(3):174-83. doi: 10.7326/M14-2948.

4.

Women in clinical research: what we need for progress.

Bucholz EM, Krumholz HM.

Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S1-3. doi: 10.1161/CIRCOUTCOMES.115.001756. Epub 2015 Feb 24. No abstract available.

5.

Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry.

Yeh RW, Czarny MJ, Normand SL, Kereiakes DJ, Holmes DR Jr, Brindis RG, Weaver WD, Rumsfeld JS, Roe MT, Kim S, Driscoll-Shempp P, Mauri L.

Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):96-102. doi: 10.1161/CIRCOUTCOMES.114.001239. Epub 2014 Nov 16.

6.

Gender analysis of moxifloxacin clinical trials.

Chilet-Rosell E, Ruiz-Cantero MT, Pardo MA.

J Womens Health (Larchmt). 2014 Jan;23(1):77-104. doi: 10.1089/jwh.2012.4171. Epub 2013 Nov 1. Review.

7.

Insights on GRACE (Gender, Race, And Clinical Experience) from the patient's perspective: GRACE participant survey.

Squires K, Feinberg J, Bridge DA, Currier J, Ryan R, Seyedkazemi S, Dayaram YK, Mrus J.

AIDS Patient Care STDS. 2013 Jun;27(6):352-62. doi: 10.1089/apc.2013.0015. Epub 2013 May 23.

8.

Inverted expression profiles of sex-biased genes in response to toxicant perturbations and diseases.

Ung CY, Lam SH, Zhang X, Li H, Zhang L, Li B, Gong Z.

PLoS One. 2013;8(2):e56668. doi: 10.1371/journal.pone.0056668. Epub 2013 Feb 14.

9.

Women and coronary artery disease. Part I: basic considerations.

Abbasi SH, Kassaian SE.

J Tehran Heart Cent. 2011 Summer;6(3):109-16. Epub 2011 Aug 31.

10.

H1N1pdm09 adjuvanted vaccination in HIV-infected adults: a randomized trial of two single versus two double doses.

Santini-Oliveira M, Camacho LA, Souza TM, Luz PM, Vasconcellos MT, Giacoia-Gripp CB, Morgado MG, Nunes EP, Lemos AS, Ferreira AC, Moreira RI, Veloso VG, Siqueira MM, Grinsztejn B.

PLoS One. 2012;7(6):e39310. doi: 10.1371/journal.pone.0039310. Epub 2012 Jun 25.

11.

Methods and baseline characteristics of a randomized trial treating early childhood obesity: the Positive Lifestyles for Active Youngsters (Team PLAY) trial.

Hare ME, Coday M, Williams NA, Richey PA, Tylavsky FA, Bush AJ.

Contemp Clin Trials. 2012 May;33(3):534-49. doi: 10.1016/j.cct.2012.02.003. Epub 2012 Feb 10.

12.

Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes.

Mosca L, Barrett-Connor E, Wenger NK.

Circulation. 2011 Nov 8;124(19):2145-54. doi: 10.1161/CIRCULATIONAHA.110.968792. No abstract available.

13.

Response by sex to statin plus ezetimibe or statin monotherapy: a pooled analysis of 22,231 hyperlipidemic patients.

Abramson BL, Benlian P, Hanson ME, Lin J, Shah A, Tershakovec AM.

Lipids Health Dis. 2011 Aug 22;10:146. doi: 10.1186/1476-511X-10-146.

14.

The impact of cardiovascular disease prevalence on women's enrollment in landmark randomized cardiovascular trials: a systematic review.

Tsang W, Alter DA, Wijeysundera HC, Zhang T, Ko DT.

J Gen Intern Med. 2012 Jan;27(1):93-8. doi: 10.1007/s11606-011-1768-8. Epub 2011 Jun 29. Review.

15.

Gender balance in cardiovascular research: importance to women's health.

Dougherty AH.

Tex Heart Inst J. 2011;38(2):148-50. No abstract available.

16.

Examining sex and gender disparities in total joint arthroplasty.

Novicoff WM, Saleh KJ.

Clin Orthop Relat Res. 2011 Jul;469(7):1824-8. doi: 10.1007/s11999-010-1765-y. Review.

17.

Enrollment of women and minorities in NINDS trials.

Burke JF, Brown DL, Lisabeth LD, Sanchez BN, Morgenstern LB.

Neurology. 2011 Jan 25;76(4):354-60. doi: 10.1212/WNL.0b013e3182088260. Epub 2011 Jan 5.

18.

Oxidative status and cardiovascular risk in women: Keeping pink at heart.

Vassalle C, Mercuri A, Maffei S.

World J Cardiol. 2009 Dec 31;1(1):26-30. doi: 10.4330/wjc.v1.i1.26.

19.

Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands.

Rodenburg EM, Stricker BH, Visser LE.

Br J Clin Pharmacol. 2011 Jan;71(1):95-104. doi: 10.1111/j.1365-2125.2010.03811.x.

20.

Sex differences in the diagnostic evaluation of coronary artery disease.

Nguyen PK, Nag D, Wu JC.

J Nucl Cardiol. 2011 Feb;18(1):144-52. doi: 10.1007/s12350-010-9315-2. Review. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk